These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 6987282)

  • 1. Hemodynamic effect of propranolol therapy in relationship to renin status and plasma catecholamines in primary hypertension.
    Vlachakis ND
    J Clin Pharmacol; 1980 Jan; 20(1):20-9. PubMed ID: 6987282
    [No Abstract]   [Full Text] [Related]  

  • 2. Beta-adrenergic blockade in essential hypertension. Effects of propranolol on hemodynamic parameters and plasma renin activity.
    Hansson L
    Acta Med Scand Suppl; 1973; 550():1-40. PubMed ID: 4201751
    [No Abstract]   [Full Text] [Related]  

  • 3. Long term treatment of moderate hypertension with the beta1-receptor blocking agent metoprolol. I. Effect on maximal working capacity, plasma catecholamines and renin, Urinary aldosterone, blood pressure and pulse rate under basal conditions.
    Hansson BG; Dymling JF; Hedeland H; Hulthén UL
    Eur J Clin Pharmacol; 1977 Apr; 11(4):239-45. PubMed ID: 324771
    [No Abstract]   [Full Text] [Related]  

  • 4. Effects of acute and long-term beta-adrenoceptor blockade with propranolol on haemodynamics, plasma catecholamines and renin in essential hypertension.
    van Baak MA; Kho TL; Thijssen H; Rahn KH
    Eur J Clin Pharmacol; 1982; 23(5):377-82. PubMed ID: 6759143
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hemodynamic and plasma renin effects of propranolol in essential hypertension.
    Mookherjee S; Eich RH; Obeid AI; Smulyan H
    Arch Intern Med; 1977 Mar; 137(3):290-5. PubMed ID: 843147
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long term treatment of moderate hypertension with the beta1-receptor blocking agent metoprolol. II. Effect of submaximal work and insulin-induced hypoglycaemia on plasma catecholamines and renin activity, blood pressure and pulse rate.
    Hansson BG; Dymling JF; Manhem P; Hökfelt B
    Eur J Clin Pharmacol; 1977 Apr; 11(4):247-54. PubMed ID: 324772
    [No Abstract]   [Full Text] [Related]  

  • 7. Hemodynamic effects of acute and prolonged beta-adrenergic blockade in essential hypertension.
    Hansson L; Zweifler AJ; Julius S; Hunyor SN
    Acta Med Scand; 1974; 196(1-2):27-34. PubMed ID: 4370849
    [No Abstract]   [Full Text] [Related]  

  • 8. Blood pressure response to norepinephrine infusion in relationship to plasma catecholamines and renin activity in man.
    Vlachakis ND
    J Clin Pharmacol; 1979 Oct; 19(10):654-61. PubMed ID: 512062
    [No Abstract]   [Full Text] [Related]  

  • 9. Nitrendipine treatment in so-called therapy-resistant arterial hypertension; effect as monotherapy and in combination with propranolol on blood pressure, heart rate, other hemodynamic parameters, plasma renin activity, and catecholamines.
    Faulhaber HD; Gruner R; Homuth V; Naumann E; Menz M; Hartrodt W; Schmidt J; Mohnike W
    J Cardiovasc Pharmacol; 1988; 12 Suppl 4():S146-8. PubMed ID: 2468860
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of propranolol on cyclic AMP excretion and plasma renin activity in labile essentrial hypertension.
    Hamet P; Kuchel O; Cuche JL; Boucher R; Genest J
    Can Med Assoc J; 1973 Dec; 109(11):1099-103. PubMed ID: 4357222
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Plasma catecholamines and hemodynamics in the course of antihypertensive beta blockade: varying patterns in "propranolol-responders" and "non-responders"].
    Bühler FR; Burkart F; Lütold BE; Bertel O; Pfisterer M
    Schweiz Med Wochenschr; 1977 Nov; 107(44):1590-1. PubMed ID: 918627
    [No Abstract]   [Full Text] [Related]  

  • 12. Blood pressure, renin activity and heart rate changes during propranolol therapy of hypertension.
    Zweifler A; Esler M
    Am J Cardiol; 1977 Jul; 40(1):105-9. PubMed ID: 879001
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of beta-adrenergic blocking agents on the blood pressure, plasma renin activity and hemodynamics of hypertensive patients.
    Matsunaga M; Hara A; Ogino K; Motohara S; Saito M
    Jpn Heart J; 1977 Jan; 18(1):24-30. PubMed ID: 15142
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Essential hypertension with low plasmatic renin activity (PRA). Effects of propranolol on some indices of adrenergic system activity].
    Aguglia F; Santucci A; Gnecchi M; Cicconetti P; De Mattia G; Balsano F
    Boll Soc Ital Cardiol; 1978; 23(8):1356-64. PubMed ID: 398714
    [No Abstract]   [Full Text] [Related]  

  • 15. Effects of prazosin on plasma renin activity and blood pressure.
    Karlberg BE; Thulin T; Fagerberg SE; Schersten B; Tolagen K; Vikesdal O; Malmberg L
    J Clin Pharmacol; 1979 Jul; 19(7):357-65. PubMed ID: 479380
    [No Abstract]   [Full Text] [Related]  

  • 16. Beta-adrenergic receptor blocking drugs, hypertension and plasma renin.
    Morgan TO; Roberts R; Carney SL; Louis WJ; Doyle AE
    Br J Clin Pharmacol; 1975 Apr; 2(2):159-64. PubMed ID: 791319
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exercise performance in mildly hypertensive patients. Impairment by propranolol but not oxprenolol.
    Franciosa JA; Johnson SM; Tobian LJ
    Chest; 1980 Aug; 78(2):291-9. PubMed ID: 6995041
    [No Abstract]   [Full Text] [Related]  

  • 18. Hemodynamic and hormonal effects of propranolol on patients with essential hypertension during head-up tilting: a comparison between normal and low cardiac index groups.
    Kida O; Morotomi Y; Higa T; Tanaka K
    Heart Vessels; 1985 Aug; 1(3):158-61. PubMed ID: 3913663
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of minoxidil on blood pressure and hemodynamics in severe hypertension.
    Bryan RK; Hoobler SW; Rosenzweig J; Weller JM; Purdy JM
    Am J Cardiol; 1977 May; 39(6):796-801. PubMed ID: 324257
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparative study of the effects of oxprenolol versus propranolol in essential hypertension.
    Gavras I; Gavras H; Sullivan PC; Tifft CP; Chobanian AV; Brunner HR
    J Clin Pharmacol; 1979 Jan; 19(1):8-14. PubMed ID: 368088
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.